Generics can’t stop heart drug cartel suit
A federal judge in New York held last week that indirect and direct purchasers had sufficiently alleged that several generic drugmakers orchestrated a scheme to fix and raise the price of propranolol hydrochloride.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10